Positive Action provides funding to community-led and community-based organisations that are committed to eliminating AIDS and supporting people living with HIV.
Funding Rounds
New Funding Opportunity for Community-Based Organisations
Positive Action invites applications targeted on testing and piloting innovative approaches that strengthen community health systems by supporting community-led innovations that increase access to and improve the uptake of HIV testing, strengthen linkage to prevention and treatment, improve retention in care and support sustained viral suppression, among disproportionally impacted populations.
Application window: 23 April 2026 – 15 May 2026
Eligible countries: Fiji, Indonesia, Malaysia, Papau New Guinea and Philippines.
Funding available: up to £100,000 over two years (up to £50,000 a year)
Proposals for the Innovator grant should focus on testing and piloting new approaches.These approaches must be new to the funding applicant but can have been delivered by another organisation in a different location or aimed at a different target population. The project should be a two-year pilot that aims to build evidence before scale-up.
Based on new HIV transmission rates in the region, as well as unmet HIV treatment need, the primary focus population for this call for proposals are disproportionally impacted populations (including women and girls, and their sexual partners).
Who can apply?
Non-governmental and community-based organisations are essential in driving change at the community level, given their strong connections with, or representation of, the populations most impacted. Positive Action places strong emphasis on localisation and equitable partnerships that align with the principles of the decolonisation agenda. We prioritise engagement with locally-led organisations – particularly those embedded within affected communities – and encourage collaboration that actively promotes local ownership, leadership, and decision-making. This commitment is integral to ensuring sustainable and culturally relevant interventions.
Download the detailed guidance note here. Please note, applications must be submitted in English.
Positive Action invites applications from 23 April 2026 (00:01 BST) to the 15th of May 2026 (23:59 BST). During the application window, Positive Action will host webinars to provide further information for applicants. The webinars will take place on 27 and 29 April 2026 at 8am BST. Both webinars will cover the same content, so applicants only need to attend one session. You can register using this link, and you will receive the calendar invitation once registered.
Completing your application
Create your account and submit your application through the Cybergrants Portal using this link.
Applications emailed to ViiV Healthcare or Positive Action staff or mailboxes will not be accepted.
If you have any question or problems accessing the online system, please contact the Positive Action mailbox: PA.Generalenquiries@viivhealthcare.com
NP-GBL-HVX-COCO-220063 | April 2026
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
